AstraZeneca is seeking a US Medical Head for COPD Biologics to lead the medical strategy and execution for a novel monoclonal antibody targeting Interleukin-33. The role requires a sophisticated scientific background and extensive experience in the pharmaceutical industry, specifically within medical affairs and respiratory diseases.
Must-have
Nice-to-have
Not specified